Skip to main content
. 2021 Apr 22;9(5):893. doi: 10.3390/microorganisms9050893

Table 2.

SARS-CoV-2 pseudovirus entry assay. Different concentrations of each compound have been tested against entry stage of the SARS-CoV-2 pseudovirus. Pseudovirus entry inhibition (%) has been defined compared to the readout of untreated sample.

Compound SARS-CoV-2 Pseudovirus Entry Inhibition (%) Compound SARS-CoV-2 Pseudovirus Entry Inhibition (%)
Baicalin, µM Baicalein, µM
30 −3.3 30 14.6
10 −6.6 10 3.9
3.3 −11.9 3.3 −1.9
1.1 −12.1 1.1 −2